• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during pregnancy and nursing is challenging for women with the condition. There is a lack of information about how long-term exposure to these drugs can affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking liquid adhd medication medications need to balance the advantages of taking them against the potential risks to the foetus. Doctors don't have enough data to give clear advice however they can provide information about risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not face an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during early pregnancy and those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure accurate case classification and to minimize the possibility of bias.

The research conducted by the researchers was not without limitations. The researchers were unable in the beginning, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the small differences observed between the exposed groups were due to the use of medication, or if they were confounded by the presence of comorbidities. The researchers did not examine the long-term effects for the offspring.

The study showed that infants whose mothers took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders, and the increased risk of admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits to both the mother and child of continued treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve coping skills which can reduce the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. Often, these decisions are taken in the absence of solid and reliable evidence either way, so physicians must weigh their knowledge about their experiences, the experiences of other doctors, and what the research suggests about the subject, along with their best non stimulant adhd medication for adults judgment for each individual patient.

The issue of possible risks for infants can be difficult to determine. The research on this subject is based on observation rather than controlled studies and many of the findings are conflicting. Most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies show a neutral or even slightly negative impact. In each case an in-depth evaluation of the risks and benefits is required.

For many women with ADHD, the decision to stop medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. In addition, a decrease in medication can affect the ability to do work-related tasks and safely drive which are essential aspects of a normal life for many people suffering from ADHD.

She suggests that women who are unsure about whether or not to stop taking medication because of their pregnancy, consider educating family members, friends and colleagues on the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. It can also make the woman feel more comfortable in her struggle with her decision. It is important to note that some medications are able to be absorbed through the placenta so if the patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug could be passed on to the baby.

Risk of Birth Defects

As the use and use of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the potential adverse effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Researchers utilized two massive datasets to analyze more than 4.3 million pregnancies and determine if stimulant medication use increased birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study could not find any association between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are in agreement with previous studies which showed an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication before pregnancy. The risk was higher during the latter part of pregnancy, when a lot of women begin to discontinue their medication.

Women who took ADHD medication in the first trimester of their pregnancy were also more likely to undergo a caesarean section, a low Apgar score after delivery and a baby who needed breathing assistance at birth. The researchers of the study could not eliminate bias due to selection because they restricted the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope their research will help doctors when they meet pregnant women. The researchers advise that while discussing benefits and risks are important, the decision about whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that even though stopping the medication is an option, it is not an option to consider due to the high rate of depression and other mental health problems for women who are expecting or postpartum. Additionally, research suggests that women who stop taking their medication will have a tough time adjusting to a life without them once the baby is born.

Nursing

It can be a stressful experience becoming a mother. Women with liquid adhd medication who have to deal with their symptoms while attending physician appointments, preparing for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed by breast milk in very small quantities, so the risk to breastfeeding infant is minimal. However, the amount of medication exposure to the newborn can vary depending on dosage, how often it is administered and at what time it is administered. Additionally, different medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't yet fully known.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medication during a woman's pregnancy. This is a difficult decision for the woman who must weigh the benefits of continuing her medication against the potential risks to the fetus. As long as more information is available, doctors can ask pregnant patients if they have an background of adhd medication without diagnosis uk medication for adhd (please click the following page) or if they plan to take medication during the perinatal phase.

A increasing number of studies have proven that most women can safely continue to take their ADHD medication during pregnancy and while breastfeeding. As a result, an increasing number of patients opt to do this, and in consultation with their doctor they have discovered that the benefits of continuing their current medication outweigh any risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD understand their symptoms and the root cause and learn about treatment options and strengthen existing coping strategies. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, and monitoring for indicators of deterioration, and, if needed modifications to the medication regime.